Logo.jpg
Biofrontera AG decides to delist ADS from Nasdaq to reduce complexity and costs
14 févr. 2022 14h05 HE | Biofrontera AG
Leverkusen, Germany, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera AG (the “Company”) (Nasdaq: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, decided today its...
Logo.jpg
Biofrontera AG announces mediation results
19 nov. 2021 08h45 HE | Biofrontera AG
Leverkusen, Germany, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (ISIN: DE0006046113) has been in mediation proceedings with Mr. Wilhelm K. T....
Logo.jpg
Biofrontera reports financial results for the third quarter and nine months ended September 30, 2021
17 nov. 2021 17h00 HE | Biofrontera AG
Leverkusen, Germany, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
Logo.jpg
Biofrontera AG: Conference call to discuss third quarter 2021 financial results to be held on November 18, 2021
09 nov. 2021 05h45 HE | Biofrontera AG
Leverkusen, Germany, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
Logo.jpg
Biofrontera AG receives FDA-approval of the BF-RhodoLED® XL lamp
22 oct. 2021 09h55 HE | Biofrontera AG
Leverkusen, Germany, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the "Company"), an international biopharmaceutical company, today announced the...
Logo.jpg
Biofrontera reports preliminary revenue for the month of August 2021
08 sept. 2021 12h10 HE | Biofrontera AG
Leverkusen, Germany, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
Logo.jpg
Biofrontera reports financial results for the six months ended June 30, 2021
19 août 2021 11h47 HE | Biofrontera AG
Leverkusen, Germany, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
Logo.jpg
Biofrontera AG: Conference call to discuss half-year 2021 financial results to be held on August 20, 2021
12 août 2021 08h55 HE | Biofrontera AG
Leverkusen, Germany, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
Logo.jpg
Biofrontera reports preliminary revenue for the month of July 2021
09 août 2021 09h00 HE | Biofrontera AG
Leverkusen, Germany, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
Logo.jpg
Biofrontera enters into license and supply agreement with Medac for the marketing of Ameluz® in Poland
23 juil. 2021 04h15 HE | Biofrontera AG
Leverkusen, Germany, July 23, 2021 (GLOBE NEWSWIRE) -- Biofrontera Pharma GmbH, a wholly owned subsidiary of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), and Medac Gesellschaft für...